281 related articles for article (PubMed ID: 26812426)
1. Effect of Fc-Glycan Structure on the Conformational Stability of IgG Revealed by Hydrogen/Deuterium Exchange and Limited Proteolysis.
Fang J; Richardson J; Du Z; Zhang Z
Biochemistry; 2016 Feb; 55(6):860-8. PubMed ID: 26812426
[TBL] [Abstract][Full Text] [Related]
2. Impact of Fc N-glycan sialylation on IgG structure.
Zhang Z; Shah B; Richardson J
MAbs; 2019; 11(8):1381-1390. PubMed ID: 31411531
[TBL] [Abstract][Full Text] [Related]
3. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
[TBL] [Abstract][Full Text] [Related]
4. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.
Goetze AM; Liu YD; Zhang Z; Shah B; Lee E; Bondarenko PV; Flynn GC
Glycobiology; 2011 Jul; 21(7):949-59. PubMed ID: 21421994
[TBL] [Abstract][Full Text] [Related]
5. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.
Anumula KR
J Immunol Methods; 2012 Aug; 382(1-2):167-76. PubMed ID: 22683540
[TBL] [Abstract][Full Text] [Related]
6. Site-specific N-glycosylation of chicken serum IgG.
Suzuki N; Lee YC
Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
[TBL] [Abstract][Full Text] [Related]
7. Simple capillary electrophoresis-mass spectrometry method for complex glycan analysis using a flow-through microvial interface.
Jayo RG; Thaysen-Andersen M; Lindenburg PW; Haselberg R; Hankemeier T; Ramautar R; Chen DD
Anal Chem; 2014 Jul; 86(13):6479-86. PubMed ID: 24873509
[TBL] [Abstract][Full Text] [Related]
8. Effect of pH, temperature, and salt on the stability of Escherichia coli- and Chinese hamster ovary cell-derived IgG1 Fc.
Li CH; Narhi LO; Wen J; Dimitrova M; Wen ZQ; Li J; Pollastrini J; Nguyen X; Tsuruda T; Jiang Y
Biochemistry; 2012 Dec; 51(50):10056-65. PubMed ID: 23078371
[TBL] [Abstract][Full Text] [Related]
9. IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.
Teplyakov A; Zhao Y; Malia TJ; Obmolova G; Gilliland GL
Mol Immunol; 2013 Nov; 56(1-2):131-9. PubMed ID: 23628091
[TBL] [Abstract][Full Text] [Related]
10. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies.
Aoyama M; Hashii N; Tsukimura W; Osumi K; Harazono A; Tada M; Kiyoshi M; Matsuda A; Ishii-Watabe A
MAbs; 2019 Jul; 11(5):826-836. PubMed ID: 30990348
[TBL] [Abstract][Full Text] [Related]
11. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods.
Reusch D; Haberger M; Maier B; Maier M; Kloseck R; Zimmermann B; Hook M; Szabo Z; Tep S; Wegstein J; Alt N; Bulau P; Wuhrer M
MAbs; 2015; 7(1):167-79. PubMed ID: 25524468
[TBL] [Abstract][Full Text] [Related]
12. Influence of glycan modification on IgG1 biochemical and biophysical properties.
Pawlowski JW; Bajardi-Taccioli A; Houde D; Feschenko M; Carlage T; Kaltashov IA
J Pharm Biomed Anal; 2018 Mar; 151():133-144. PubMed ID: 29324282
[TBL] [Abstract][Full Text] [Related]
13. Crystal Structure of a Homogeneous IgG-Fc Glycoform with the N-Glycan Designed to Maximize the Antibody Dependent Cellular Cytotoxicity.
Chen CL; Hsu JC; Lin CW; Wang CH; Tsai MH; Wu CY; Wong CH; Ma C
ACS Chem Biol; 2017 May; 12(5):1335-1345. PubMed ID: 28318221
[TBL] [Abstract][Full Text] [Related]
14. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.
Mimura Y; Ashton PR; Takahashi N; Harvey DJ; Jefferis R
J Immunol Methods; 2007 Sep; 326(1-2):116-26. PubMed ID: 17714731
[TBL] [Abstract][Full Text] [Related]
15. The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development.
Brady LJ; Velayudhan J; Visone DB; Daugherty KC; Bartron JL; Coon M; Cornwall C; Hinckley PJ; Connell-Crowley L
MAbs; 2015; 7(3):562-70. PubMed ID: 25898160
[TBL] [Abstract][Full Text] [Related]
16. Insights into substrate recognition and specificity for IgG by Endoglycosidase S2.
Aytenfisu AH; Deredge D; Klontz EH; Du J; Sundberg EJ; MacKerell AD
PLoS Comput Biol; 2021 Jul; 17(7):e1009103. PubMed ID: 34310592
[TBL] [Abstract][Full Text] [Related]
17. Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.
More AS; Toth RT; Okbazghi SZ; Middaugh CR; Joshi SB; Tolbert TJ; Volkin DB; Weis DD
J Pharm Sci; 2018 Sep; 107(9):2315-2324. PubMed ID: 29751008
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of effects of Fc domain high-mannose glycan on antibody stability.
Lu Y; Westland K; Ma YH; Gadgil H
J Pharm Sci; 2012 Nov; 101(11):4107-17. PubMed ID: 22927056
[TBL] [Abstract][Full Text] [Related]
19. [A stable conformer of IgG, prepared by an acidic influence: study by calorimetry, binding of the C1q complement component, and monospecific anti-IgG].
Kravchuk ZI; Vlasov AP; Liakhnovich GV; Martsev SP
Biokhimiia; 1994 Oct; 59(10):1458-77. PubMed ID: 7819387
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Aggregation Propensity of a Human Fc-Fusion Protein Therapeutic by Hydrogen/Deuterium Exchange Mass Spectrometry.
Huang RY; Iacob RE; Krystek SR; Jin M; Wei H; Tao L; Das TK; Tymiak AA; Engen JR; Chen G
J Am Soc Mass Spectrom; 2017 May; 28(5):795-802. PubMed ID: 27527097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
